This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
08/28/15 - 3:49:42 PM ET (BATS BZX Real-time Price)
Div Yield: --
CYTK Day's Range
CYTK 52 Week Range
CYTK Business Summary
Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions.View CYTK key stats
Cytokinetics Inc - CYTK - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Cytokinetics Inc as a
Sell with a ratings score of D.
Report Snippet: We rate CYTOKINETICS INC (CYTK) a SELL. This is driven by a few notable weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and feeble growth in its earnings per share.